Journal
CYTOKINE
Volume 71, Issue 2, Pages 394-396Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.cyto.2014.11.014
Keywords
Retinal pigment epithelium; TGF-beta; Embryonic stem cell; Proliferative vitreoretinopathy; Polarity
Funding
- NIH [EYO1545]
- Core Grant Research to Prevent Blindness, New York [EY03040]
- Keck School of Medicine Dean's Research Scholars Program
- Arnold and Mabel Beckman Foundation
Ask authors/readers for more resources
Retinal pigmented epithelium (RPE) secretes transforming growth factor beta 1 and 2 (TGF-beta 1 and -beta 2) cytokines involved in fibrosis, immune privilege, and proliferative vitreoretinopathy (PVR). Since RPE cell polarity may be altered in various disease conditions including PVR and age-related macular degeneration, we determined levels of TGF-beta from polarized human RPE (hRPE) and human stem cell derived RPE (hESC-RPE) as compared to nonpolarized cells. TGF-beta 2 was the predominant isoform in all cell culture conditions. Nonpolarized cells secreted significantly more TGF-beta 2 supporting the contention that loss of polarity of RPE in PVR leads to rise of intravitreal TGF-beta 2. Active TGF-beta 2, secreted mainly from apical side of polarized RPE, represented 6-10% of total TGF-beta 2. In conclusion, polarity is an important determinant of TGF-beta 2 secretion in RPE. Low levels of apically secreted active TGF-beta 2 may play a role in the normal physiology of the subretinal space. Comparable secretion of TGF-beta from polarized hESC-RPE and hRPE supports the potential for hESC-RPE in RPE replacement therapies. (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available